Atlas Trials

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Clinical trial NCT05010629 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05010629
Sponsor
Glenn J. Hanna
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Salivary Gland CancerRecurrent Salivary Gland CancerMetastatic CancerAdenoid Cystic Carcinoma
Start date
2021-09-17
Primary completion
2025-02-14
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.